The road to virtual control groups and the importance of proper body-weight selection

Main Article Content

Alexander Gurjanov , Lea A. I. Vaas, Thomas Steger-Hartmann
[show affiliations]

Abstract

Virtual control groups (VCGs) created from historical control data (HCD) can reduce the number of concurrent control group animals needed in regulatory toxicity studies by up to 25%. This study investigates the performance of VCGs on statistical outcomes of body weight development between treatment and control groups in legacy studies. The objective is to reproduce the statistical outcomes of 28-day sub-chronic studies (legacy studies) after replacing the concurrent control group with virtual ones. In rodent toxicity studies initial body weight is used as surrogate for the age of animals. For the assessment of VCG-sampling methods three different approaches are explored: (i) sampling VCGs from the entire HCD ignoring initial body weight information of the legacy study, (ii) sampling from HCD matching the legacy study’s initial body weights, and (iii) sampling from HCD with assigned statistical weights derived from legacy study initial body weight information. It is shown that the ability to reproduce statistical outcomes by virtual controls is mainly determined by the congruence between the legacy study and the HCD weight distribution: regardless of the chosen approach, the ability to reproduce statistical outcomes was well for VCGs when the legacy study’s initial-body-weight distribution was similar to the HCD’s. When the initial body weight range of the legacy study was at the extreme ends of the HCD’s distribution, the weighted-sampling approach was superior. This article highlights the importance of proper HCD-matching by the legacy study’s initial body weight and discusses required conditions to accurately reproduce body weight development.


Plain language summary
Animal control data from past studies performed in a standardized manner can be used to create virtual control groups (VCGs) to use in new studies instead of control animals. This approach can reduce the number of study animals by up to 25%. This study assesses the performance of VCGs selected by body weight in rat studies. The objective was to reproduce the original study results as closely as possible after replacing the original control group values with VCGs from a pool of historical control values. Several methods for selecting control animal data to create VCGs were compared. Among these, assigning statistical weights to the sampling pool yielded the best performance. Ideally the body weight distributions on day 1 of the study should be similar between the VCG and the original study animals. This article shows that proper selection VCGs can yield reliable study data with fewer animals.

Article Details

How to Cite
Gurjanov, A., Vaas, L. A. I. and Steger-Hartmann, T. (2024) “The road to virtual control groups and the importance of proper body-weight selection”, ALTEX - Alternatives to animal experimentation. doi: 10.14573/altex.2403141.
Section
Short Communications
References

Dunnett, C. W. (1955). A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association 50, 1096-1121. https://doi.org/10.1080/01621459.1955.10501294.

Du Sert, N. P., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., Browne, W. J., ... & Würbel, H. (2020). Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS biology, 18(7), e3000411. https://doi.org/10.1371/journal.pbio.3000411.

Golden, E., Allen, D., Amberg, A. et al. (2023). Toward implementing virtual control groups in nonclinical safety studies: Workshop report and roadmap to implementation. ALTEX-Alternatives to animal experimentation. https://doi.org/10.14573/altex.2310041.

Gurjanov, A., Kreuchwig, A., Steger-Hartmann, T. et al. (2023). Hurdles and signposts on the road to virtual control groups—a case study illustrating the influence of anesthesia protocols on electrolyte levels in rats. Frontiers in Pharmacology 14, 1142534. https://doi.org/10.3389/fphar.2023.1142534.

Gurjanov, A. (2024) VCG Initial Body Weight [Software]. GitHub. https://github.com/Bayer-Group/VCG-INITBW.

Gurjanov, A., Vieira-Vieira, C., Vienenkoetter, J. et al. (2024). Replacing concurrent controls with virtual control groups in rat toxicity studies. Regulatory Toxicology and Pharmacology, 105592. https://doi.org/10.1016/j.yrtph.2024.105592.

Hamada, C. (2018). Statistical analysis for toxicity studies. Journal of toxicologic pathology 31, 15-22. https://doi.org/10.1293/tox.2017-0050.

Hoffman, W. P., Ness, D. K., van Lier, R. B. L.. (2002). Analysis of Rodent Growth Data in Toxicology Studies, Toxicological Sciences, 66, 2, 313–319, https://doi.org/10.1093/toxsci/66.2.313.

Hothorn, L. A. (2016). The two-step approach—a significant anova f-test before dunnett's comparisons against a control—is not recommended. Communications in Statistics-Theory and Methods 45, 3332-3343. https://doi.org/10.1080/03610926.2014.902225.

ICH (2009). Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals m3 (r2). International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m3r2-non-clinical-safety-studies-conduct-human-clinical-trials-and-marketing-authorisation-pharmaceuticals-step-5_en.pdf.

Howard, B. R. (2002). Control of variability. ILAR journal, 43(4), 194-201. https://doi.org/10.1093/ilar.43.4.194.

Jacob Filho, W., Lima, C. C., Paunksnis, M. R. R. et al. (2018). Reference database of hematological parameters for growing and aging rats. The Aging Male 21, 145-148. https://doi.org/10.1080/13685538.2017.1350156.

Kluxen, F. M., Weber, K., Strupp, C. et al. (2021). Using historical control data in bioassays for regulatory toxicology. Regulatory Toxicology and Pharmacology 125, 105024. https://doi.org/10.1016/j.yrtph.2021.105024.

McCutcheon, J. E. and Marinelli, M. (2009). Age matters. European Journal of Neuroscience 29, 997-1014. https://doi.org/10.1111/j.1460-9568.2009.06648.x.

Namdari, R., Jones, K., Chuang, S. S. et al. (2021). Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice. Regulatory Toxicology and Pharmacology 126, 105029. https://doi.org/10.1016/j.yrtph.2021.105029.

OECD (2008). Test no. 407: Repeated dose 28-day oral toxicity study in rodents. Vol. https://www.oecd-ilibrary.org/content/publication/9789264070684-en doi:doi: https://doi.org/10.1787/9789264070684-en.

Russel, W. M. S. and Burch, R. L. . The principles of humane experimental technique. Methuen, 1959. http://117.239.25.194:7000/jspui/bitstream/123456789/1342/1/PRILIMINERY%20%20AND%20%20CONTENTS.pdf.

Steger-Hartmann, T., Kreuchwig, A., Vaas, L. et al. (2020). Introducing the concept of virtual control groups into preclinical toxicology testing. ALTEX-Alternatives to animal experimentation 37, 343-349. https://doi.org/10.14573/altex.2001311.

Steger-Hartmann, T. and Clark, M. (2023). Can historical control group data be used to replace concurrent controls in animal studies? Toxicologic Pathology 01926233231208987. https://doi.org/10.1177/01926233231208987.

Talbot, S. R., Biernot, S., Bleich, A. et al. (2020). Defining body-weight reduction as a humane endpoint: A critical appraisal. Laboratory animals 54, 99-110. https://doi.org/10.1177/0023677219883319.

Wolford, S., Schroer, R., Gallo, P. et al. (1987). Age-related changes in serum chemistry and hematology values in normal sprague-dawley rats. Fundamental and Applied Toxicology 8, 80-88. https://doi.org/10.1016/0272-0590(87)90102-3.

Wright, P. S., Smith, G. F., Briggs, K. A. et al. (2023). Retrospective analysis of the potential use of virtual control groups in preclinical toxicity assessment using the etox database. Regulatory Toxicology and Pharmacology 138, 105309. https://doi.org/10.1016/j.yrtph.2022.105309.

Most read articles by the same author(s)